Article
Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
PLoS pathogens - 1 Mar 2014
Kearney Mary F, Spindler Jonathan, Shao Wei, Yu Sloane, Anderson Elizabeth M, O'Shea Angeline, Rehm Catherine, Poethke Carry, Kovacs Nicholas, Mellors John W, Coffin John M, Maldarelli Frank
Abstract excerpt
A better understanding of changes in HIV-1 population genetics with combination antiretroviral therapy (cART) is critical for designing eradication strategies. We therefore analyzed HIV-1 genetic variation and divergence in patients' plasma before cART, during suppression on cART, and after viral rebound. Single-genome sequences of plasma HIV-1 RNA were obtained from HIV-1 infected patients prior to cART...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
